Physician

Kara Dixon Capriotti, M.D.

According to 2025 Medicare claims, Kara Capriotti, M.D. (NPI: 1669689352) practices dermatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is BRYN MAWR SKIN & CANCER LLP (NPI: 1346205242; TIN: 232731751) and primary practice location at 19010-1353.

Capriotti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,419 traditional Medicare patients, billed 7,141 HCPCS/CPT codes, and received $992,154 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 491 prescription claims across 289 beneficiaries totaling $69,346 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 66 records totaling $1,260. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $48,716 to $69,346. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,011	6,907	$721,954
2016	1,153	8,014	$929,173
2017	1,164	7,741	$972,745
2018	1,184	8,177	$1,123,828
2019	1,185	8,096	$1,199,112
2020	1,138	6,596	$1,029,563
2021	1,207	7,490	$1,221,581
2022	1,272	6,815	$1,118,959
2023	1,364	7,233	$1,165,269
2024	1,419	7,141	$992,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	425	$48,716
2016	233	456	$198,829
2017	219	382	$63,150
2018	182	347	$68,982
2019	184	306	$46,050
2020	214	365	$31,403
2021	242	388	$12,221
2022	220	343	$12,829
2023	250	409	$28,256
2024	289	491	$69,346

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	528	677	$470
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	605	769	$83
11102	Biopsy of related skin growth, first growth	411	541	$59
17000	Destruction of precancer skin growth, 1 growth	452	609	$32
88305	Pathology examination of tissue using a microscope, intermediate complexity	379	645	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	12	336	$47,008
Jublia	Efinaconazole	11	330	$8,417
Fluorouracil	Fluorouracil	16	471	$968
Clobetasol Propionate	Clobetasol Propionate	28	1,020	$748
Metronidazole	Metronidazole	14	410	$622

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$1,260	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kara Dixon Capriotti, M.D.?

Tedicare shows public-source Medicare data for Kara Dixon Capriotti, M.D. (NPI 1669689352), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kara Dixon Capriotti, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kara Dixon Capriotti, M.D.?

Kara Dixon Capriotti, M.D. is linked to BRYN MAWR SKIN & CANCER LLP (billing NPI 1346205242) in the available physician profile data.

Does Kara Dixon Capriotti, M.D. have Open Payments data?

Kara Dixon Capriotti, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.